1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Welcome back my Onc brothers and sisters.

Discussion in 'Ortho Biotech' started by Anonymous, Aug 29, 2014 at 4:05 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    We are now positioned to run JnJ again! Many of us had to be dispersed around to stay afloat. But we are back! I look forward to growing onward and upward with the powerhouse crew. Sell em and close em. Rack em and break em!